The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives
Open Access
- 23 October 2021
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 22 (12) , 1-22
Abstract
Opinion statement: New molecular insights are being achieved in synovial sarcoma (SS) that can provide new potential diagnostic and prognostic markers as well as therapeutic targets. In particular, the advancement of research on epigenomics and gene regulation is promising. The concrete hypothesis that the pathogenesis of SS might mainly depend on the disruption of the balance of the complex interaction between epigenomic regulatory complexes and the consequences on gene expression opens interesting new perspectives. The standard of care for primary SS is wide surgical resection combined with radiation in selected cases. The role of chemotherapy is still under refinement and can be considered in patients at high risk of metastasis or in those with advanced disease. Cytotoxic chemotherapy (anthracyclines, ifosfamide, trabectedin, and pazopanib) is the treatment of choice, despite several possible side effects. Many possible drug-able targets have been identified. However, the impact of these strategies in improving SS outcome is still limited, thus making current and future research strongly needed to improve the survival of patients with SS.Keywords
Funding Information
- Alma Mater Studiorum - Università di Bologna
This publication has 208 references indexed in Scilit:
- Epidemiology and therapies for metastatic sarcomaClinical Epidemiology, 2013
- Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial SarcomaCell, 2013
- A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomasEuropean Journal of Cancer, 2012
- Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new casesTumor Biology, 2012
- PCGF Homologs, CBX Proteins, and RYBP Define Functionally Distinct PRC1 Family ComplexesMolecular Cell, 2012
- Roles of the Polycomb group proteins in stem cells and cancerCell Death & Disease, 2011
- Risk Assessment Based on FDG-PET Imaging in Patients with Synovial SarcomaClinical Orthopaedics and Related Research, 2008
- Neuronal Differentiation of Synovial Sarcoma and Its Therapeutic ApplicationClinical Orthopaedics and Related Research, 2008
- Synovial Sarcoma: From Genetics to Genetic-based Animal ModelingClinical Orthopaedics and Related Research, 2008
- Repression by Groucho/TLE/Grg Proteins: Genomic Site Recruitment Generates Compacted Chromatin In Vitro and Impairs Activator Binding In VivoMolecular Cell, 2007